Todd Richard Fisher, MD | |
300 E Main St, Hummelstown, PA 17036-1725 | |
(717) 566-1100 | |
(717) 566-0600 |
Full Name | Todd Richard Fisher |
---|---|
Gender | Male |
Speciality | Family Practice |
Experience | 39 Years |
Location | 300 E Main St, Hummelstown, Pennsylvania |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1336104504 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Q00000X | Family Medicine | MD036336E (Pennsylvania) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Southeastern Home Care Services Of Pa, Llc | Elizabethtown, PA | Home health agency |
Pinnacle Health Hospitals | Harrisburg, PA | Hospital |
Milton S Hershey Medical Center | Hershey, PA | Hospital |
Holy Spirit Hospital | Camp hill, PA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Todd R. Fisher Md, Pc | 2163466087 | 4 |
News Archive
Cancer Research UK scientists have identified an important new protein target which could be used to produce highly focused vaccine therapies for cancer - according to research published in the Journal of Clinical Investigation.
Researchers have identified what they believe is the original source of malignant malaria: a parasite found in chimpanzees in equatorial Africa.
Alma Lasers, a global developer, manufacturer and provider of laser, light-based, radiofrequency and ultrasound devices for aesthetic and medical applications announced today they will be joining the millions of supporters committed to fighting breast cancer through awareness, education and research.
XOMA Ltd., a leader in the discovery and development of therapeutic antibodies, announced the initiation of a Phase 2 clinical trial of XOMA 052, its antibody to interleukin-1 beta (IL-1 beta), in Type 1 diabetes patients. Funding for the trial is being provided by the Juvenile Diabetes Research Foundation International, the largest patient advocacy organization of Type 1 diabetes research worldwide.
› Verified 6 days ago
Entity Name | Todd R. Fisher Md, Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1295792083 PECOS PAC ID: 2163466087 Enrollment ID: O20050613000358 |
News Archive
Cancer Research UK scientists have identified an important new protein target which could be used to produce highly focused vaccine therapies for cancer - according to research published in the Journal of Clinical Investigation.
Researchers have identified what they believe is the original source of malignant malaria: a parasite found in chimpanzees in equatorial Africa.
Alma Lasers, a global developer, manufacturer and provider of laser, light-based, radiofrequency and ultrasound devices for aesthetic and medical applications announced today they will be joining the millions of supporters committed to fighting breast cancer through awareness, education and research.
XOMA Ltd., a leader in the discovery and development of therapeutic antibodies, announced the initiation of a Phase 2 clinical trial of XOMA 052, its antibody to interleukin-1 beta (IL-1 beta), in Type 1 diabetes patients. Funding for the trial is being provided by the Juvenile Diabetes Research Foundation International, the largest patient advocacy organization of Type 1 diabetes research worldwide.
› Verified 6 days ago
Mailing Address | Practice Location Address |
---|---|
Todd Richard Fisher, MD 300 E Main St, Hummelstown, PA 17036-1725 Ph: (717) 566-1100 | Todd Richard Fisher, MD 300 E Main St, Hummelstown, PA 17036-1725 Ph: (717) 566-1100 |
News Archive
Cancer Research UK scientists have identified an important new protein target which could be used to produce highly focused vaccine therapies for cancer - according to research published in the Journal of Clinical Investigation.
Researchers have identified what they believe is the original source of malignant malaria: a parasite found in chimpanzees in equatorial Africa.
Alma Lasers, a global developer, manufacturer and provider of laser, light-based, radiofrequency and ultrasound devices for aesthetic and medical applications announced today they will be joining the millions of supporters committed to fighting breast cancer through awareness, education and research.
XOMA Ltd., a leader in the discovery and development of therapeutic antibodies, announced the initiation of a Phase 2 clinical trial of XOMA 052, its antibody to interleukin-1 beta (IL-1 beta), in Type 1 diabetes patients. Funding for the trial is being provided by the Juvenile Diabetes Research Foundation International, the largest patient advocacy organization of Type 1 diabetes research worldwide.
› Verified 6 days ago
Dr. Dudley R Gordon, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 8105 Adams Dr, Hummelstown, PA 17036 Phone: 717-652-1211 Fax: 717-652-4948 | |
Joseph Franklin Thomas, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 655 Hershey Rd, Hummelstown, PA 17036 Phone: 717-566-3796 | |
Sean Patrick Rhoads, PA-C Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 605 E Main St, Hummelstown, PA 17036 Phone: 717-566-1100 Fax: 717-566-0600 | |
Dr. John E Muscalus Jr., DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 655 Hershey Rd, Hummelstown, PA 17036 Phone: 717-566-3796 Fax: 717-566-0576 | |
Dr. Marko Adam Miljkovic, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 1440 Deerfield Dr, Hummelstown, PA 17036 Phone: 717-566-6670 |